CClaimWatch
Claims closedsecurities

Perrigo Securities Litigation Settlement

This settlement is closed to new claims. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →

What happened

Perrigo Company plc and former CEO Joseph C. Papa allegedly violated federal securities laws by making false and misleading statements and omissions regarding the performance and integration of Omega Pharma N.V., which Perrigo acquired in early 2015, and regarding Perrigo's pricing strategy, noncompetitive practices, and the competitive environment for its generic prescription drug unit. The defendants have settled for $97 million without admitting wrongdoing.

Do you qualify?

Anyone who purchased Perrigo Company plc's publicly traded common stock between April 21, 2015 and May 2, 2017 on the New York Stock Exchange or other U.S. trading centers, or between those dates on the Tel Aviv Stock Exchange; also anyone who owned Perrigo common stock on November 12, 2015 and held it through at least 8:00 a.m. on November 13, 2015, regardless of whether they tendered shares in the Mylan tender offer.

How to file

Claims administration has been completed and distributions have begun. For information on your claim status or to receive settlement funds, contact the Claims Administrator JND Legal Administration at 1-833-674-0175, email info@perrigosecuritieslitigation.com, or mail Perrigo Securities Litigation, c/o JND Legal Administration, PO Box 91374, Seattle, WA 98111.

This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.

More securities settlements

View all →